| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/12/2004 | EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis |
| 05/12/2004 | EP1115818B1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 05/12/2004 | EP1067966B1 Ophthalmic composition comprising a beta-blocker |
| 05/12/2004 | EP1054662B1 Water-soluble eye drop |
| 05/12/2004 | EP1043937A4 Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby |
| 05/12/2004 | EP1037667B1 Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 05/12/2004 | EP1019027A4 Implantable collagen-containing putty material |
| 05/12/2004 | EP0961651B1 Method & apparatus for the formation of particles |
| 05/12/2004 | EP0710261B1 Biodegradable particles |
| 05/12/2004 | EP0627912B1 Gels for encapsulation of biological materials |
| 05/12/2004 | CN2614676Y Capsules for multi-layer medicines |
| 05/12/2004 | CN1496275A Transdermal electrotransport device and method for mfg. same |
| 05/12/2004 | CN1496272A Bicarbonate-based solutions for dialysis therapies |
| 05/12/2004 | CN1496270A Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 05/12/2004 | CN1496265A Medicine for fighting against sexual dysfunction |
| 05/12/2004 | CN1496258A Methods of administering epothilone analogs for treatment of cancer |
| 05/12/2004 | CN1496253A 新组合物 The new composition |
| 05/12/2004 | CN1496241A Radiation cross-linked hydrogels |
| 05/12/2004 | CN1495829A Method for making cathode-ray tube matrix |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1495250A Method for purifying tagetes oil-containing resin |
| 05/12/2004 | CN1494921A Erythropoietin oral lozenge and its preparation method |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1494919A Embonate medicine composition containing bombesin-like product |
| 05/12/2004 | CN1494916A Chinese medicine composition for promoting bllod circulation and its preparation method |
| 05/12/2004 | CN1494914A Prduction method of holothurian oral lozenge |
| 05/12/2004 | CN1494911A Slowly-reteased preparation of erythromycin derivative |
| 05/12/2004 | CN1494908A Stable tibolone composition |
| 05/12/2004 | CN1494903A Preventing or curing agent for eye fatigue and pseudomyopia |
| 05/12/2004 | CN1494902A Application of high-solubility berberine in preparation of medicine. |
| 05/12/2004 | CN1494901A Yanming qingsong plaster and it preparation method |
| 05/12/2004 | CN1494900A Slow releasing composition and its preparing method |
| 05/12/2004 | CN1494899A Slowly-released dosage form containing asperline |
| 05/12/2004 | CN1494898A Valacycloguanosine tablet containing colloid silica |
| 05/12/2004 | CN1494885A Granulation method of raw medicine component preparation |
| 05/12/2004 | CN1494837A Xinjian tobacco. health-care cigarette |
| 05/12/2004 | CN1149283C Stable transglutaminase preparations and processer for producing them |
| 05/12/2004 | CN1149101C Green porphyrins as immunomodulators |
| 05/12/2004 | CN1149099C Capsule for treating cholasma and acne and its preparing process |
| 05/12/2004 | CN1149095C Chinese medicine for treating baby's congenital heart disease |
| 05/12/2004 | CN1149092C Acid resistant enteric coated capsule of active binding bifidobacterium strain |
| 05/12/2004 | CN1149083C Pharmaceutical compositions containing irbesartan |
| 05/12/2004 | CN1149080C Prilocaine and hydrofluorocarbon aerosol preparations |
| 05/12/2004 | CN1149079C Process for preparing micro pills containing medicine by high-speed stirring and fusion |
| 05/12/2004 | CN1149078C Treatment of chronic inflammatory disorders of gastrointestinal tract |
| 05/12/2004 | CN1149077C Rapidly disintegrable solid preparation |
| 05/12/2004 | CN1149076C Preparation of powder agglomerates |
| 05/12/2004 | CN1149075C Enteric coated pharmaceutical compsn, and method of mfg. |
| 05/12/2004 | CN1149073C Medicinal aerosol products |
| 05/12/2004 | CN1149072C New pharmaceutical composition with anaesthetic effect |
| 05/12/2004 | CN1149071C Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said prparation |
| 05/12/2004 | CN1149021C Liquid oral compositions comprising a calcium compound and an acidulant |
| 05/11/2004 | US6734195 Stable donepezil hydrochloride amorphous tablet for the treatment of dementia or alzheimer's disease |
| 05/11/2004 | US6734188 Composition for treatment of constipation and irritable bowel syndrome |
| 05/11/2004 | US6734170 Cellular uptake of bioactive agents |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734008 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/11/2004 | US6733796 Saw palmetto extract provided in an oral controlled release formulation; maintenance of therapeutic levels of active agents in the bloodstream for prolonged periods of time. |
| 05/11/2004 | US6733792 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 05/11/2004 | US6733791 Sublingual compositions comprising thymosin fraction 5 and methods for administration thereof |
| 05/11/2004 | US6733790 Heating an aqueous solution of a gel former, an anionic polymer selected from a salt of alginic acid and an anionic chitosan derivative, then adding to an aqueous solution of chitosan; stability in the presence of anionic surfactants |
| 05/11/2004 | US6733789 Polymeric coating with a ph-dependent dissolution delay with sustained release for nighttime administration |
| 05/11/2004 | US6733788 Temperature controlled solute delivery system |
| 05/11/2004 | US6733787 Applying to defect a biocompatible, bioerodable, adhesive water soluble polymer |
| 05/11/2004 | US6733785 Moisture-sensitive preparation of percutaneous absorption type |
| 05/11/2004 | US6733784 Coated, platform-generating tablet |
| 05/11/2004 | US6733783 Controlled release hydrocodone formulations |
| 05/11/2004 | US6733782 Core tablet for controlled release of gliclazide after oral administration |
| 05/11/2004 | US6733781 Fast dissolving tablet |
| 05/11/2004 | US6733780 Direct compression polymer tablet core |
| 05/11/2004 | US6733778 Ph stabilizing agent lysine or arginine in pellet core, which is directly enteric coated without a separating layer |
| 05/11/2004 | US6733777 Cationic reagents of transfection |
| 05/11/2004 | US6733776 Treating androgenic alopecia; an antisense nucleic acid molecule that hybridizes to an androgen receptor gene so as to inhibit androgen receptor expression; an expression system therefor; and an antiandrogen |
| 05/11/2004 | US6733775 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 05/11/2004 | US6733767 Liquid polymeric compositions for controlled release of bioactive substances |
| 05/11/2004 | US6733763 Using antigen; oil in water emulsion |
| 05/11/2004 | US6733754 Adjuvants for use in vaccines |
| 05/11/2004 | US6733751 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 05/11/2004 | US6733749 Comprises lytic enzyme composition for infecting bacteria (streptococcus pheumoniae and hemophilus influenza), and carrier (candy, lozenge, etc.) |
| 05/11/2004 | US6733745 Devices with coatings containing chlorhexidine gluconate, compositions and methods |
| 05/11/2004 | US6733446 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
| 05/11/2004 | US6732738 Method to enhance healing of sternum after sternotomy |
| 05/11/2004 | CA2312898C Long acting injectable formulations containing hydrogenated castor oil |
| 05/11/2004 | CA2272442C Lozenge for the modified releasing of active substances in the gastrointestinal tract |
| 05/11/2004 | CA2226153C Process for producing active substances from unused or discarded devices for the transdermal administration of active substances and/or from their production waste |
| 05/11/2004 | CA2225960C Pharmaceutical compositions |
| 05/11/2004 | CA2188785C Melt granulated sucralfate preparations and a process for their production |
| 05/11/2004 | CA2156481C 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 05/11/2004 | CA2115308C Uncoated tablets and method of producing the same |
| 05/11/2004 | CA2104594C Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 05/11/2004 | CA2101779C Defoaming composition |
| 05/11/2004 | CA2062341C Use of hydrophilic penetrating agents in dermatological compositions for the treatment of onychomycosis, and corresponding compositions |
| 05/08/2004 | WO2004064828A1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 05/06/2004 | WO2004038460A2 Aqueous ophthalmic spray and method for delivery |
| 05/06/2004 | WO2004038428A2 Controlled-release compositions |
| 05/06/2004 | WO2004037899A2 Chitosan pellets |
| 05/06/2004 | WO2004037726A1 Production of water for injection using reverse osmosis |
| 05/06/2004 | WO2004037402A1 Method for the production of powdered active substance formulations by means of compressible fluids |
| 05/06/2004 | WO2004037318A2 Method and system for intravesicular delivery of therapeutic agents |
| 05/06/2004 | WO2004037316A2 Nanoparticle delivery system |